Postponement of a Major OEM Project and Impairment Loss on Fixed Assets
First written in FY2016. 6 of 8 entries say "Restated". Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024MaterialisedAnnual report
「OEM product sales declined because North American customers adjusted their orders amid deteriorating business conditions, while delays in global ocean transportation delayed deliveries to customers.」
Sales risks related to major OEM projects became actual drivers of lower sales through order adjustments by North American customers amid deteriorating business conditions and delivery delays caused by delays in ocean transportation. - FY2018RestatedAnnual report
「Sales of the fully automated genetic testing system supplied as an OEM product to ELITechGroup and own-brand sales performed well, but weak sales to some existing OEM customers resulted in lower revenue year on year overall.」
The situation in which weak sales to some existing OEM customers affect overall results has continued. - FY2018-Q2RestatedAnnual report
「Sales of the fully automated genetic diagnostic system supplied as an OEM product to ELITechGroup and own-brand sales performed well, but sales to existing OEM customers were weak, resulting in lower revenue and profit year on year overall.」
Weak sales to existing OEM customers continued, reaffirming that OEM customer sales conditions affect overall results. - FY2017RestatedAnnual report
「Sales of the fully automated genetic testing system geneLEAD Ⅻ Plus doubled year on year and progressed steadily through OEM partners. However, the impact of a temporary suspension of product shipments at some OEM partners was substantial, resulting in lower sales year on year.」
The suspension of shipments by some OEM customers continued to be cited as a factor behind lower full-year sales. - FY2017-Q3RestatedAnnual report
「Meanwhile, the significant impact of a temporary suspension of product shipments at some major OEM customers resulted in lower sales and profit year on year.」
The suspension of product shipments at some major OEM customers and its impact on results continued to be reported in the third quarter. - FY2017-Q2RestatedAnnual report
「Meanwhile, the significant impact of a temporary suspension of product shipments at some major OEM customers resulted in lower sales and profit year on year.」
The suspension of product shipments at some major OEM customers and its impact on results continued to be reported in the current quarter. - FY2017-Q1RestatedAnnual report
「The significant impact of a temporary suspension of product shipments at some major OEM customers resulted in lower sales and profit year on year.」
In connection with the postponement of major OEM projects reported in the previous fiscal year and the uncertainty surrounding their resumption, the company stated that the suspension of shipments at some major OEM customers continued to affect results in the current quarter. - FY2016MaterialisedAnnual report
「At some major OEM customers, the sales outlook for projects that we had expected to make a significant contribution to sales growth from the next fiscal year onward was substantially delayed, and the timing of their resumption remains unclear at present. Accordingly, because indications of impairment were identified in connection with our business, we decided to recognize an impairment loss of ¥908 million as an extraordinary loss in the consolidated financial statements for the fiscal year ended June 2016.」
The postponement of OEM project sales actually occurred, and an impairment loss of ¥908 million on fixed assets was recognized.